Press Release

Fountain Therapeutics Moves Corporate Headquarters to Lilly Gateway Labs in South San Francisco

Fountain Therapeutics (“Fountain”), a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing cellular age, today announced it has moved its corporate headquarters to Lilly Gateway Labs in South San Francisco upon selection by Eli Lilly and Company. The company joins a select group of emerging biotech companies spearheading innovation in drug …

Fountain Therapeutics Moves Corporate Headquarters to Lilly Gateway Labs in South San Francisco Read More »

Fountain Therapeutics Closes $6 Million Series A-1 Financing

Closing brings total Series A financing sum to $11 million Funds to support expansion of team, technology platform and in vivo preclinical drug testing SAN FRANCISCO, May 19, 2020 (GLOBE NEWSWIRE) — Fountain Therapeutics (“Fountain”), a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing cellular age, today announced the closing of a …

Fountain Therapeutics Closes $6 Million Series A-1 Financing Read More »

Scroll to Top